Human cytomegalovirus riding the cell cycle

Medical Microbiology and Immunology

Volumn 204, Issue 3, 2015, Pages 409-419

  Spector, Deborah H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anaphase promoting complex; Cell cycle; Cyclin dependent kinases; Cyclins; Human cytomegalovirus

Indexed keywords

ANAPHASE PROMOTING COMPLEX; CELL CYCLE PROTEIN; CYCLIN A; CYCLIN B; CYCLIN DEPENDENT KINASE; DNA; PROTEASOME; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3; VIRUS DNA; IMMEDIATE EARLY PROTEIN; VIRUS PROTEIN;

ANAPHASE; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL FUNCTION; CYTOMEGALOVIRUS INFECTION; DNA REPLICATION; DNA SYNTHESIS; GENE EXPRESSION; HOST CELL; HUMAN; HUMAN CYTOMEGALOVIRUS; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN STABILITY; REVIEW; RNA TRANSCRIPTION; VIRUS REPLICATION; CELL CYCLE CHECKPOINT; CYTOMEGALOVIRUS; GENETICS; HOST PATHOGEN INTERACTION; METABOLISM; PHYSIOLOGY; VIROLOGY;

ANAPHASE-PROMOTING COMPLEX-CYCLOSOME; CELL CYCLE; CELL CYCLE CHECKPOINTS; CYCLIN A; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA REPLICATION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMEDIATE-EARLY PROTEINS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84929959710     PISSN: 03008584     EISSN: 14321831     Source Type: Journal    
DOI: 10.1007/s00430-015-0396-z     Document Type: Review

References (97)

1. Mocarski ES, Shenk T, Pass RF (2007) Cytomegaloviruses. In: Knipe DM, Howley PM (eds) Fields virology, vol 2, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 2701–2772
2. Murray AW (2004) Recycling the cell cycle: cyclins revisited. Cell 116:221–234
3. Satyanarayana A, Kaldis P (2009) Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms. Oncogene 28:2925–2939
4. Teixeira LK, Reed SI (2013) Ubiquitin ligases and cell cycle control. Annu Rev Biochem 82:387–414
5. Blow JJ, Dutta A (2005) Preventing re-replication of chromosomal DNA. Nat Rev Mol Cell Biol 6:476–486
6. Bottazzi ME, Buzzai M, Zhu X, Desdouets C, Brechot C, Assoian RK (2001) Distinct effects of mitogens and actin cytoskeleton on CREB and pocket protein phosphorylation control the extent and timing of cyclin A promoter activity. Mol Cell Biol 21:7607–7616
7. Desdouets C, Matesic G, Molina CA, Foulkes NS, Sassone-Corsi P, Bréchot C, Sobszak-Thepot J (1995) Cell cycle regulation of cyclin A gene expression by the cyclic AMP transcription factors CREB and CREM. Mol Cell Biol 15:3301–3309
8. Henglein B, Chenivesse X, Wang J, Eick D, Bréchot C (1994) Structure and cell cycle-regulated transcription of the human cyclin A gene. Proc Natl Acad Sci USA 91:5490–5494
9. Zwicker J, Muller R (1997) Cell-cycle regulation of gene expression by transcriptional repression. Trends Genet 13:3–6
10. Glotzer M, Murray AW, Kirschner MW (1991) Cyclin is degraded by the ubiquitin pathway. Nature 349:132–138
11. Tessari MA, Gostissa M, Altamura S, Sgarra R, Rustighi A, Salvagno C, Caretti G, Imbriano C, Mantovani R, Sal GD et al (2003) Transcriptional activation of the cyclin A gene by the architectural transcription factor HMGA2. Mol Cell Biol 23:9104–9116
12. Schulze A, Zerfass K, Spitkovsky D, Middendorp S, Berges J, Helin K, Jansen-Dürr P, Henglein B (1995) Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. Proc Natl Acad Sci USA 92:11264–11268
13. Zwicker J, Lucibello FC, Wolfraim LA, Gross C, Truss M, Engeland K, Muller R (1995) Cell cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression. EMBO J 14:4514–4522
14. Nishitani H, Lygerou Z (2002) Control of DNA Replication. Genes Cells 7:523–534
15. Machida YJ, Hamlin JL, Dutta A (2005) Right place, right time, and only once: replication initiation in metazoans. Cell 123:13–24
16. Millar JBA, Russell P (1992) The cdc25 M-phase inducer: an unconventional protein phosphatase. Cell 68:407–410
17. McGarry TJ, Kirschner MW (1998) Geminin, an inhibitor of DNA replication, is degraded during mitosis. Cell 93:1043–1053
18. Brandeis M, Hunt T (1996) The proteolysis of mitotic cyclins in mammalian cells persists from the end of mitosis until the onset of S phase. EMBO J 15:5280–5289
19. Lukas J, Lukas C, Bartek J (2004) Mammalian cell cycle checkpoints: signalling pathways and their organization in space and time. DNA Repair 3:997–1007
20. Dyson N (1998) The regulation of E2F by pRB-family proteins. Genes Dev 12:2245–2262
21. Narasimha AM, Kaulich M, Shapiro GS, Choi YJ, Sicinski P, Dowdy SF (2014) Cyclin D activates the Rb tumor suppressor by mono-phosphorylation. Elife 3:e02872
22. Slee EA, O’Connor DJ, Lu X (2004) To die or not to die: how does p53 decide? Oncogene 23:2809–2818
23. Vousden KH, Lu X (2002) Live or let die: the cell’s response to p53. Nat Rev 2:594–604
24. Lavin MF, Gueven N (2006) The complexity of p53 stabilization and activation. Cell Death Differ 13:941–950
25. Bresnahan WA, Boldogh I, Thompson EA, Albrecht T (1996) Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1. Virology 224:156–160
26. Dittmer D, Mocarski ES (1997) Human cytomegalovirus infection inhibits G1/S transition. J Virol 71:1629–1634
27. Jault FM, Jault J-M, Ruchti F, Fortunato EA, Clark C, Corbeil J, Richman DD, Spector DH (1995) Cytomegalovirus infection induces high levels of cyclins, phosphorylated RB, and p53, leading to cell cycle arrest. J Virol 69:6697–6704
28. Lu M, Shenk T (1996) Human cytomegalovirus infection inhibits cell cycle progression at multiple points, including the transition from G1 to S. J Virol 70:8850–8857
29. Salvant BS, Fortunato EA, Spector DH (1998) Cell cycle dysregulation by human cytomegalovirus: influence of the cell cycle phase at the time of infection and effects on cyclin transcription. J Virol 72:3729–3741
30. 1. J Virol 73:9274–9283
31. Wiebusch L, Hagemeier C (2001) The human cytomegalovirus immediate early 2 protein dissociates cellular DNA synthesis from cyclin dependent kinase activation. EMBO J 20:1086–1098
32. Hertel L, Mocarski ES (2004) Global analysis of host cell gene expression late during cytomegalovirus infection reveals extensive dysregulation of cell cycle gene expression and induction of pseudomitosis independent of US28 function. J Virol 78(21):11988–12011
33. Challacombe JF, Rechtsteiner A, Gottardo R, Rocha LM, Browne EP, Shenk T, Altherr MR, Brettin TS (2004) Evaluation of the host transcriptional response to human cytomegalovirus infection. Physiol Genomics 18:51–62
34. Sanchez V, McElroy AK, Spector DH (2003) Mechanisms governing maintenance of cdk1/cyclin B1 kinase activity in cells infected with human cytomegalovirus. J Virol 77:13214–13224
35. Shlapobersky M, Sanders R, Clark C, Spector DH (2006) Repression of HMGA2 gene expression by human cytomegalovirus involves the IE2 86-kilodalton protein and is necessary for efficient viral replication and inhibition of cyclin A transcription. J Virol 80:9951–9961
36. Caffarelli N, Fehr AR, Yu D (2013) Cyclin A degradation by primate cytomegalovirus protein pUL21a counters its innate restriction of virus replication. PLoS Pathog 9(12):e1003825
37. Eifler M, Uecker R, Weisbach H, Bogdanow B, Richter E, Konig L, Vetter B, Lenac-Rovis T, Jonjic S, Neitzel H et al (2014) PUL21a-Cyclin A2 interaction is required to protect human cytomegalovirus-infected cells from the deleterious consequences of mitotic entry. PLoS Pathog 10(10):e1004514
38. Casavant NC, Luo MH, Rosenke K, Winegardner T, Zurawska A, Fortunato EA (2006) Potential role for p53 in the permissive life cycle of human cytomegalovirus. J Virol 80:8390–8401
39. Fortunato EA, Spector DH (1998) p53 and RPA are sequestered in viral replication centers in the nuclei of cells infected with human cytomegalovirus. J Virol 72:2033–2039
40. Muganda P, Mendoza O, Hernandez J, Qian Q (1994) Human cytomegalovirus elevates levels of the cellular protein p53 in infected fibroblasts. J Virol 68:8028–8034
41. Chen Z, Knutson E, Kurosky A, Albrecht T (2001) Degradation of p21cip1 in cells productively infected with human cytomegalovirus. J Virol 75:3613–3625
42. Biswas N, Sanchez V, Spector DH (2003) Human cytomegalovirus infection leads to accumulation of geminin and inhibition of the licensing of cellular DNA replication. J Virol 77:2369–2376
43. McElroy AK, Dwarakanath RS, Spector DH (2000) Dysregulation of cyclin E gene expression in human cytomegalovirus-infected cells requires viral early gene expression and is associated with changes in the Rb-related protein p130. J Virol 74:4192–4206
44. Grey F, Tirabassi R, Meyers H, Wu G, McWeeney S, Hook L, Nelson JA (2010) A viral microRNA down-regulates multiple cell cycle genes through mRNA 5’UTRs. PLoS Pathog 6:e1000967
45. 1 phase of the cell cycle. J Virol 73:676–683
46. Hayashi ML, Blankenship C, Shenk T (2000) Human cytomegalovirus UL69 is required for efficient accumulation of infected cells in the G1 phase of the cell cycle. Proc Natl Acad Sci USA 97(6):2692–2696
47. Ayoubi TA, Jansen E, Meulemans SM, Van de Ven WJ (1999) Regulation of HMGIC expression: an architectural transcription factor involved in growth control and development. Oncogene 18:5076–5087
48. Lischka P, Toth Z, Thomas M, Mueller R, Stamminger T (2006) The UL69 transactivator protein of human cytomegalovirus interacts with DEXD/H-Box RNA helicase UAP56 to promote cytoplasmic accumulation of unspliced RNA. Mol Cell Biol 26(5):1631–1643
49. Cygnar D, Hagemeier S, Kronemann D, Bresnahan WA (2012) The cellular protein SPT6 is required for efficient replication of human cytomegalovirus. J Virol 86:2011–2020
50. Dunn C, Chalupny NJ, Sutherland CL, Dosch S, Sivakumar PV, Johnson DC, Cosman D (2003) Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J Exp Med 197:1427–1439
51. Bresnahan WA, Hultman GE, Shenk T (2000) Replication of wild-type and mutant human cytomegalovirus in life-extended human diploid fibroblasts. J Virol 74:10816–10818
52. Kalejta RF, Bechtel JT, Shenk T (2003) Human cytomegalovirus pp71 stimulates cell cycle progression by inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors. Mol Cell Biol 23:1885–1895
53. Cantrell SR, Bresnahan WA (2005) Interaction between the human cytomegalovirus UL82 gene product (pp71) and hDaxx regulates immediate-early gene expression and viral replication. J Virol 79:7792–7802
54. Ishov AM, Vladimirova OV, Maul GG (2002) Daxx-mediated accumulation of human cytomegalovirus tegument protein pp71 at ND10 facilitates initiation of viral infection at these nuclear domains. J Virol 76(15):7705–7712
55. Hofmann H, Sindre H, Stamminger T (2002) Functional interaction between the pp71 protein of human cytomegalovirus and the PML-interacting protein human Daxx. J Virol 76(11):5769–5783
56. Marshall KR, Rowley KV, Rinaldi A, Nicholson IP, Ishov AM, Maul GG, Preston CM (2002) Activity and intracellular localization of the human cytomegalovirus protein pp71. J Gen Virol 83:1601–1612
57. Saffert RT, Kalejta RF (2006) Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression. J Virol 80:3863–3871
58. Lukashchuk V, McFarlane S, Everett RD, Preston CM (2008) Human cytomegalovirus protein pp71 displaces the chromatin-associated factor ATRX from nuclear domain 10 at early stages of infection. J Virol 82:12543–12554
59. Preston CM, Nicholl MJ (2006) Role of the cellular protein hDaxx in human cytomegalovirus immediate-early gene expression. J Gen Virol 87:1113–1121
60. Hwang J, Kalejta RF (2007) Proteasome-dependent, ubiquitin-independent degradation of Daxx by the viral pp71 protein in human cytomegalovirus-infected cells. Virology 367:334–338
61. Castillo JP, Yurochko A, Kowalik TF (2000) Role of human cytomegalovirus immediate-early proteins in cell growth control. J Virol 74:8028–8037
62. Castillo JP, Frame FM, Rogoff HA, Pickering MT, Yurochko AD, Kowalik TF (2005) Human cytomegalovirus IE1-72 activates ataxia telangiectasia mutated kinase and a p53/p21-mediated growth arrest response. J Virol 79(17):11467–11475
63. Speir E, Modali R, Huang E-S, Leon MB, Sahwl F, Finkel T, Epstein SE (1994) Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265:391–394
64. Bonin LR, McDougall JK (1997) Human cytomegalovirus IE2 86-kilodalton protein binds p53 but does not abrogate G1 checkpoint function. J Virol 71:5861–5870
65. Hagemeier C, Caswell R, Hayhurst G, Sinclair J, Kouzarides T (1994) Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein. EMBO J 13:2897–2903
66. Sommer MH, Scully AL, Spector DH (1994) Trans-activation by the human cytomegalovirus IE2 86 kDa protein requires a domain that binds to both TBP and RB. J Virol 68:6223–6231
67. Fortunato EA, Sommer MH, Yoder K, Spector DH (1997) Identification of domains within the human cytomegalovirus major immediate-early 86-kilodalton protein and the retinoblastoma protein required for physical and functional interaction with each other. J Virol 71:8176–8185
68. Song Y-J, Stinski MF (2002) Effect of the human cytomegalovirus IE86 protein on expression of E2F responsive genes: a DNA microarray analysis. Proc Natl Acad Sci USA 99:2836–2841
69. Wiebusch L, Asmar J, Uecker R, Hagemeier C (2003) Human cytomegalovirus immediate-early protein 2 (IE2)-mediated activation of cyclin E is cell-cycle-independent and forces S-phase entry in IE2-arrested cells. J Gen Virol 84:51–60
70. Murphy EA, Streblow DN, Nelson JA, Stinski MF (2000) The human cytomegalovirus IE86 protein can block cell cycle progression after inducing transition into the S phase of the cell cycle. J Virol 74:7108–7118
71. Noris E, Zannetti C, Demurtas A, Sinclair J, De Andrea M, Gariglio M, Landolfo S (2002) Cell cycle arrest by human cytomegalovirus 86-kDa IE2 protein resembles premature senescence. J Virol 76(23):12135–12148
72. Song YJ, Stinski MF (2005) Inhibition of cell division by the human cytomegalovirus IE86 protein: role of the p53 pathway or cyclin-dependent kinase 1/cyclin B1. J Virol 79:2597–2603
73. Poole E, Bain M, Teague L, Takei Y, Laskey R, Sinclair J (2012) The cellular protein MCM3AP is required for inhibition of cellular DNA synthesis by the IE86 protein of human cytomegalovirus. PLoS One 7(10):e45686
74. Bresnahan WA, Albrecht T, Thompson EA (1998) The cyclin E promoter is activated by human cytomegalovirus 86-kDa immediate early protein. J Biol Chem 273:22075–22082
75. White EA, Spector DH (2005) Exon 3 of the human cytomegalovirus major immediate-early region is required for efficient viral gene expression and for cellular cyclin modulation. J Virol 79:7438–7452
76. Ciechanover A (1994) The ubiquitin–proteasome proteolytic pathway. Cell 79:13–21
77. Hershko A, Ciechanover A (1998) The ubiquitin system. Annu Rev Biochem 67:425–479
78. Eguren M, Manchado E, Malumbres M (2011) Non-mitotic functions of the anaphase-promoting complex. Semin Cell Dev Biol 22(6):572–578
79. Fehr AR, Yu D (2013) Control the host cell cycle: viral regulation of the anaphase-promoting complex. J Virol 87(16):8818–8825
80. Chang L, Zhang Z, Yang J, McLaughlin SH, Barford D (2014) Molecular architecture and mechanism of the anaphase-promoting complex. Nature 513(7518):388–393
81. Wiebusch L, Bach M, Uecker R, Hagemeier C (2005) Human cytomegalovirus inactivates the G0/G1-APC/C ubiquitin ligase by Cdh1 dissociation. Cell Cycle 4:1435–1439
82. Sanchez V, Spector DH (2006) Cyclin-dependent kinase activity is required for efficient expression and posttranslational modification of human cytomegalovirus proteins and for production of extracellular particles. J Virol 80:5886–5896
83. Wiebusch L, Uecker R, Hagemeier C (2003) Human cytomegalovirus prevents replication licensing by inhibiting MCM loading onto chromatin. EMBO Rep 4(1):42–46
84. Tran K, Kamil JP, Coen DM, Spector DH (2010) Inactivation and disassembly of the anaphase-promoting complex during human cytomegalovirus infection is associated with degradation of the APC5 and APC4 subunits and does not require UL97-mediated phosphorylation of Cdh1. J Virol 84:10832–10843
85. Tran K, Mahr JA, Choi J, Teodoro JG, Green MR, Spector DH (2008) Accumulation of substrates of the anaphase-promoting complex (APC) during human cytomegalovirus infection is associated with the phosphorylation of Cdh1 and the dissociation and relocalization of the APC subunits. J Virol 82:529–537
86. Fehr AR, Gualberto NC, Savaryn JP, Terhune SS, Yu D (2012) Proteasome-dependent disruption of the E3 ubiquitin ligase anaphase-promoting complex by HCMV protein pUL21a. PLoS Pathog 8:e1002789
87. Fortunato EA, Sanchez V, Yen JY, Spector DH (2002) Infection of cells with human cytomegalovirus during S phase results in a blockade to immediate-early gene expression that can be overcome by inhibition of the proteasome. J Virol 76:5369–5379
88. Zydek M, Hagemeier C, Wiebusch L (2010) Cyclin-dependent kinase activity controls the onset of the HCMV lytic cycle. PLoS Pathog 6:e1001096
89. Zydek M, Uecker R, Tavalai N, Stamminger T, Hagemeier C, Wiebusch L (2011) General blockade of human cytomegalovirus immediate-early mRNA expression in the S/G2 phase by a nuclear, Daxx- and PML-independent mechanism. J Gen Virol 92:2757–2769
90. Sanchez V, McElroy AK, Yen J, Tamrakar S, Clark CL, Schwartz RA, Spector DH (2004) Cyclin-dependent kinase activity is required at early times for accurate processing and accumulation of the human cytomegalovirus UL122-123 and UL37 immediate-early transcripts and at later times for virus production. J Virol 78(20):11219–11232
91. Tamrakar S, Kapasi AJ, Spector DH (2005) Human cytomegalovirus infection induces specific hyperphosphorylation of the carboxyl-terminal domain of the large subunit of RNA polymerase II that is associated with changes in the abundance, activity, and localization of cdk9 and cdk7. J Virol 79:15477–15493
92. Kapasi AJ, Spector DH (2008) Inhibition of the cyclin-dependent kinases at the beginning of the human cytomegalovirus infection specifically alters the levels and localization of the RNA polymerase II carboxyl-terminal domain kinases cdk9 and cdk7 at the viral transcriptosome. J Virol 82:394–407
93. Maul GG, Negorev D (2008) Differences between mouse and human cytomegalovirus interactions with their respective hosts at immediate early times of the replication cycle. Med Microbiol Immunol 197:241–249
94. Wiebusch L, Neuwirth A, Grabenhenrich L, Voigt S, Hagemeier C (2008) Cell cycle-independent expression of immediate-early gene 3 results in G1 and G2 arrest in murine cytomegalovirus-infected cells. J Virol 82:10188–10198
95. Oduro JD, Uecker R, Hagemeier C, Wiebusch L (2012) Inhibition of human cytomegalovirus immediate-early gene expression by cyclin A2-dependent kinase activity. J Virol 86(17):9369–9383
96. Bogdanow B, Weisbach H, von Einem J, Straschewski S, Voigt S, Winkler M, Hagemeier C, Wiebusch L (2013) Human cytomegalovirus tegument protein pp150 acts as a cyclin A2-CDK-dependent sensor of the host cell cycle and differentiation state. Proc Natl Acad Sci USA 110(43):17510–17515
97. Qian Z, Leung-Pineda V, Xuan B, Piwnica-Worms H, Yu D (2010) Human cytomegalovirus protein pUL117 targets the mini-chromosome maintenance complex and suppresses cellular DNA synthesis. PLoS Pathog 6:e1000814